ADA2 p.Arg34=
c.102G>A · rs113192455 · VCV794661
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -1.3 | GERP -3.5 |
| Overall | ||
| CADD | 0.782 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.00667% | 15,004 |
| Remaining individualsnot grpmax-eligible | 0.0064% | 15,626 |
| East Asian | 0.00223% | 44,872 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ADA2
- Protein
- p.Arg34=
- Coding
- c.102G>A
- MANE Select
- NM_001166105 · reported on NM_001282225
- dbSNP
- rs113192455
- Type
- single nucleotide variant
- Location
- chr22:17209576 (GRCh38)
- Structure
- AlphaFold pLDDT 85.04 · 1 PDB
- Residue 34
- a binding site
Disease context
deficiency of adenosine deaminase 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Deficiency of adenosine deaminase 2 (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood, Infancy
- Prevalence
- <1 / 1 000 000 (Worldwide)
Similar variants
- ADA2 p.Arg34Gln Uncertain significance ★ ⚠ same residue
- ADA2 p.Arg34Pro Uncertain significance ★ ⚠ same residue
- ADA2 p.Arg34Trp Conflicting classifications of pathogenicity ★ ⚠ same residue
- ADA2 c.754-2A>G Likely pathogenic ★★ same condition
- ADA2 c.882-2A>G Pathogenic ★★ same condition
- ADA2 c.973-2A>G Pathogenic ★★ same condition
- ADA2 p.Arg169Gln Pathogenic/Likely pathogenic ★★ ⚠ same condition
- ADA2 p.Arg169Trp Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ada2-p-arg34 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown